Heinz‐Wolfram Bernd

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Heike Horn, Marita Ziepert, Claudia Becher et al. · Blood · 2013 · 544 citations

Medicine, Hematology, Oncology +11

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

Eva Hoster, Andreas Rosenwald, Françoise Berger et al. · Journal of Clinical Oncology · 2016 · 362 citations

Medicine, Oncology, Pathology +17

Clinical Impact of the Cell-of-Origin Classification and the <i>MYC</i> / <i>BCL2</i> Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

Annette M. Staiger, Marita Ziepert, Heike Horn et al. · Journal of Clinical Oncology · 2017 · 219 citations

Medicine, Hematology, Oncology +15

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

German Ott, Marita Ziepert, Heike Horn et al. · Blood · 2010 · 202 citations · Full text

Veterinary Medicine, Hematology, Oncology +15

MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas

Anja Roehle, Kai P. Hoefig, Dirk Repsilber et al. · British Journal of Haematology · 2008 · 193 citations · Full text

Life Sciences, Hematology, Oncology +16